RXcelebs
 
877-RX-CELEBS info@rxcelebs.com REQUEST MORE INFO
   
HOME WHO WE ARE WHAT MAKES US UNIQUE OUR SERVICES OUR CLIENTS OUR WORK INDUSTRY NEWS
 
CONTACT US
 
Home > NewsIndustry News > Healthcare Updates
  Medical News Today
Prostate cancer: PSA screening does lower death risk, says review
Tue, 05 Sep 2017 00:00:00 PDT
A new review suggests that - contrary to current USPSTF guidelines - PSA screening significantly reduces the risk of death to prostate cancer.
FDA approves new antibacterial drug
Thu, 31 Aug 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific...
FDA approval brings first gene therapy to the United States
Thu, 31 Aug 2017 06:00:00 PDT
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other...
'Accelerated approval' drugs: How well are they studied?
Thu, 17 Aug 2017 00:00:00 PDT
When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and Drug Administration (FDA) has special programs available to...
FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia
Fri, 04 Aug 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with...
FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia
Wed, 02 Aug 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic...
FDA approves Vosevi for Hepatitis C
Thu, 20 Jul 2017 00:00:00 PDT
The U.S. Food and Drug Administration has approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.
FDA approves new treatment to reduce the risk of breast cancer returning
Tue, 18 Jul 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.
FDA approves new treatment for sickle cell disease
Mon, 10 Jul 2017 06:00:00 PDT
First approval for this rare blood disorder in nearly 20 years.The U.S. Food and Drug Administration has approved Endari (L-glutamine oral powder) for patients age five years and older with...
FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy
Tue, 04 Jul 2017 06:00:00 PDT
The U.S. Food and Drug Administration has cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy.
Cosmetic complaints climb but products still on market
Wed, 28 Jun 2017 00:00:00 PDT
Study highlights poor reporting to the FDA of potentially harmful cosmetic products and calls for better data along with policy changes.
New study exposes major flaws in US drugs with 'accelerated' approval
Fri, 09 Jun 2017 00:00:00 PDT
A new study has exposed major flaws in the fast tracking of some drugs available to the American public without any stringent clinical evidence of their benefits.
FDA approves first generic Strattera for the treatment of ADHD
Wed, 31 May 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
FDA approves first cancer treatment for any solid tumor with a specific genetic feature
Thu, 25 May 2017 00:00:00 PDT
The U.S. Food and Drug Administration has granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).
Nearly 1 in 3 drugs found to have safety concerns after FDA approval
Thu, 11 May 2017 00:00:00 PDT
How often are safety concerns raised about a drug after it's been approved by the FDA?
FDA approves new combination treatment for acute myeloid leukemia
Tue, 02 May 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation...
FDA approves first treatment for a form of Batten disease
Mon, 01 May 2017 00:00:00 PDT
The U.S. Food and Drug Administration has approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease.
FDA expands approved use of Stivarga to treat liver cancer
Fri, 28 Apr 2017 06:00:00 PDT
The U.S. Food and Drug Administration has expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been...
Medical marijuana laws linked to greater increase in illicit use, disorders
Wed, 26 Apr 2017 09:00:00 PDT
A new study published in JAMA Psychiatry finds that states with medical marijuana laws have seen a higher increase in illicit marijuana use and disorders.
FDA approves first drug to treat tardive dyskinesia
Wed, 12 Apr 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.
FDA approves two hepatitis C drugs for pediatric patients
Mon, 10 Apr 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to...
FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Fri, 07 Apr 2017 06:00:00 PDT
The U.S. Food and Drug Administration has allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions.
FDA approves drugs more quickly than peer agency in Europe
Fri, 07 Apr 2017 00:00:00 PDT
The U.S. Food and Drug Administration (FDA) reviews and approves new medicines in a shorter timeframe than its peer agency in Europe, the European Medicines Agency (EMA), says a Yale researcher.
The war on tobacco: Latest estimates show need for 'renewed and sustained' efforts on control policies
Thu, 06 Apr 2017 06:00:00 PDT
More than one in 10 deaths worldwide (equivalent to 6.4 million deaths) are caused by smoking and half of these occur in just four countries - China, India, USA, and Russia, according to the latest...
FDA approves new drug to treat multiple sclerosis
Thu, 30 Mar 2017 06:00:00 PDT
The U.S. Food and Drug Administration has approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).
 
 
© 2009 Rx Celebs, LLC